相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Early Allograft Dysfunction Following Liver Transplant: Impact of Obesity, Diabetes, and Red Blood Cell Transfusion
Jana Hudcova et al.
TRANSPLANTATION PROCEEDINGS (2021)
Early Allograft Dysfunction After Liver Transplantation With Donation After Circulatory Death and Brain Death Grafts: Does the Donor Type Matter?
Laura Ioana Mazilescu et al.
TRANSPLANTATION DIRECT (2021)
Comparison of the New Viscoelastic Coagulation Analyzer ClotPro® With ROTEM® Delta and Conventional Coagulation Tests in Critically Ill Patients With COVID-19
Lukas Infanger et al.
FRONTIERS IN MEDICINE (2021)
The concept of rebalanced hemostasis in patients with liver disease: Communication from the ISTH SSC working group on hemostatic management of patients with liver disease
Ton Lisman et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2021)
Using Rotational Thromboelastometry to Identify Early Allograft Dysfunction after Living Donor Liver Transplantation
Chen-Fang Lee et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Untangling Sex Dimorphisms in Coagulation Initial Steps Toward Precision Medicine for Trauma Resuscitation
Julia R. Coleman et al.
ANNALS OF SURGERY (2020)
Temporal Changes in Fibrinolysis following Injury
Hunter B. Moore et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2020)
The Differential Influence of Cold Ischemia Time on Outcome After Liver Transplantation for Different Indications-Who Is at Risk? A Collaborative Transplant Study Report
Vladimir J. Lozanovski et al.
FRONTIERS IN IMMUNOLOGY (2020)
Pre-Liver Transplant ROTEM (TM) Clot Lysis Index Is Associated with 30-Day Mortality, But Is Not a Measure for Fibrinolysis
Matthias Hartmann et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Risk factors, surgical complications and graft survival in liver transplant recipients with early allograft dysfunction
Douglas Bastos-Neves et al.
HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL (2019)
Fibrinolysis Shutdown in Trauma: Historical Review and Clinical Implications
Hunter B. Moore et al.
ANESTHESIA AND ANALGESIA (2019)
Time course and outcomes associated with transient versus persistent fibrinolytic phenotypes after injury: A nested, prospective, multicenter cohort study
Derek J. Roberts et al.
JOURNAL OF TRAUMA AND ACUTE CARE SURGERY (2019)
Fibrinolysis Shutdown Is Associated With Thrombotic and Hemorrhagic Complications and Poorer Outcomes After Liver Transplantation
Ramona Nicolau-Raducu et al.
LIVER TRANSPLANTATION (2019)
Goal-directed Management of Coagulation
Yanik J. Bababekov et al.
TRANSPLANTATION (2018)
Perioperative Coagulation Management in Liver Transplant Recipients
Dmitri Bezinover et al.
TRANSPLANTATION (2018)
Review: The Perioperative Use of Thromboelastography for Liver Transplant Patients
R. B. Hawkins et al.
TRANSPLANTATION PROCEEDINGS (2018)
Persistent Fibrinolysis Shutdown Is Associated with Increased Mortality in Severely Injured Trauma Patients
Jonathan P. Meizoso et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2017)
Fibrinolysis shutdown is associated with a fivefold increase in mortality in trauma patients lacking hypersensitivity to tissue plasminogen activator
Hunter B. Moore et al.
JOURNAL OF TRAUMA AND ACUTE CARE SURGERY (2017)
Platelet transfusions reduce fibrinolysis but do not restore platelet function during trauma hemorrhage
Paul Vulliamy et al.
JOURNAL OF TRAUMA AND ACUTE CARE SURGERY (2017)
Fibrinolysis shutdown is associated with a fivefold increase in mortality in trauma patients lacking hypersensitivity to tissue plasminogen activator
Hunter B. Moore et al.
JOURNAL OF TRAUMA AND ACUTE CARE SURGERY (2017)
Platelet transfusions reduce fibrinolysis but do not restore platelet function during trauma hemorrhage
Paul Vulliamy et al.
JOURNAL OF TRAUMA AND ACUTE CARE SURGERY (2017)
Trending Fibrinolytic Dysregulation Fibrinolysis Shutdown in the Days After Injury Is Associated With Poor Outcome in Severely Injured Children
Christine M. Leeper et al.
ANNALS OF SURGERY (2017)
Liver Transplantation and Donor Body Mass Index >30: Use or Refuse?
Anne Andert et al.
ANNALS OF TRANSPLANTATION (2016)
Reperfusion Shutdown: Delayed Onset of Fibrinolysis Resistance after Resuscitation from Hemorrhagic Shock Is Associated with Increased Circulating Levels of Plasminogen Activator Inhibitor-1 and Postinjury Complications
Hunter B. Moore et al.
BLOOD (2016)
Viscoelastic measurements of platelet function, not fibrinogen function, predicts sensitivity to tissue-type plasminogen activator in trauma patients
H. B. Moore et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2015)
Thrombin-activatable Fibrinolysis Inhibitor (TAFI) as a Novel Prognostic Factor After Orthotropic Liver Transplantation: A Pilot Study
W. L. Nedel et al.
TRANSPLANTATION PROCEEDINGS (2015)
Hyperfibrinolysis, physiologic fibrinolysis, and fibrinolysis shutdown: The spectrum of postinjury fibrinolysis and relevance to antifibrinolytic therapy
Hunter B. Moore et al.
JOURNAL OF TRAUMA AND ACUTE CARE SURGERY (2014)
Hypercoagulability as a contributor to thrombotic complications in the liver transplant recipient
Freeha Arshad et al.
LIVER INTERNATIONAL (2013)
Discrepant Fibrinolytic Response in Plasma and Whole Blood during Experimental Endotoxemia in Healthy Volunteers
Sisse R. Ostrowski et al.
PLOS ONE (2013)
Should a Lower Quality Organ Go to the Least Sick Patient? Model for End-Stage Liver Disease Score and Donor Risk Index as Predictors of Early Allograft Dysfunction
K. P. Croome et al.
TRANSPLANTATION PROCEEDINGS (2012)
Validation of a Current Definition of Early Allograft Dysfunction in Liver Transplant Recipients and Analysis of Risk Factors
Kim M. Olthoff et al.
LIVER TRANSPLANTATION (2010)
TAFIa, PAI-1 and α2-antiplasmin:: complementary roles in regulating lysis of thrombi and plasma clots
N. J. Mutch et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2007)
Characteristics associated with liver graft failure: The concept of a donor risk index
S Feng et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2006)
Optimal cut-point and its corresponding youden index to discriminate individuals using pooled blood samples
EF Schisterman et al.
EPIDEMIOLOGY (2005)
Recombinant factor VIIa improves clot formation but not fibrolytic potential in patients with cirrhosis and during liver transplantation
T Lisman et al.
HEPATOLOGY (2002)
分享论文
